Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)

by Natasha F. Sabur, Mantaj S. Brar, Lisa Wu, Sarah K. Brode
Published 2021-03-01

Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada

by Sarah K. Brode, Alex Marchand-Austin, Frances B. Jamieson, Theodore K. Marras
Published 2017-11-01

Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada

by Maria Luisa Aznar, Theodore K. Marras, Ahmed Said Elshal, Mahtab Mehrabi, Sarah K. Brode
Published 2019-06-01

Multidrug-Resistant Tuberculosis: Treatment and Outcomes of 93 Patients

by Sarah K Brode, Robert Varadi, Jane McNamee, Nina Malek, Sharon Stewart, Frances B Jamieson, Monica Avendano
Published 2015-01-01

Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012

by Lauren C. Ramsay, Emily Shing, John Wang, Theodore K. Marras, Jeffrey C. Kwong, Sarah K. Brode, Frances B. Jamieson, Beate Sander
Published 2020-09-01

Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001–2013

by Sarah K. Brode, Hannah Chung, Michael A. Campitelli, Jeffrey C. Kwong, Alex Marchand-Austin, Kevin L. Winthrop, Frances B. Jamieson, Theodore K. Marras
Published 2019-07-01

Pulmonary Nontuberculous Mycobacteria–Associated Deaths, Ontario, Canada, 2001–2013

by Theodore K. Marras, Michael A. Campitelli, Hong Lu, Hannah Chung, Sarah K. Brode, Alex Marchand-Austin, Kevin L. Winthrop, Andrea S. Gershon, Jeffrey C. Kwong, Frances B. Jamieson
Published 2017-03-01